We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
MedXY AI/MedXY News/Section: Clinical Updates

Synergistic Impact of Probiotic and Omega-3 Supplementation Combined with Ultra-Short Race Pace Training on Sprint Swimming Performance

MedXY Editorial Team•Oct 3, 2025•Clinical Updates
omega-3 fatty acids

Introduction

Swimming, particularly sprint disciplines, demands exceptional anaerobic power, neuromuscular responsiveness, and efficient recovery to maximize competitive performance. Beyond rigorous training, nutritional strategies that modulate systemic inflammation, immune function, and nutrient absorption have emerged as promising adjuncts to enhance athletic adaptation. Probiotic supplementation, through beneficial modulation of gut microbiota, supports intestinal barrier integrity and immune defenses, potentially mitigating exercise-induced stress. Concurrently, omega-3 fatty acids, notably EPA and DHA, exert anti-inflammatory actions and favor muscle protein synthesis pathways, contributing to improved recovery and muscle function. Ultra-short race pace training (USRPT) represents a targeted high-intensity interval approach that mimics competitive sprint swimming demands by subdividing race distances into brief, maximal-effort repetitions, promoting physiological adaptations specific to sprint performance execution.

This article synthesizes recent evidence assessing the combined effects of probiotics and omega-3 fatty acid supplementation alongside USRPT on sprint swimming performance. We highlight physiological mechanisms, study design, key outcomes, and clinical implications for optimizing swimmer training and nutrition.

MedXY registered readers

Sign in free to continue reading

Create or use your MedXY account to unlock the complete article.

This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.

Related articles

Open language-specific specialty feeds and department pages.

Adjunctive Omega-3 Supplementation Does Not Improve Pediatric Major Depressive Disorder: Insights from a Multi-Center Randomized TrialA multi-center randomized clinical trial involving 257 youths found that adjunctive omega-3 fatty acids (1.5 g/d) did not outperform placebo in treating moderate-to-severe pediatric major depressive disorder, despite high adherence and concJan 6, 2026Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression: Insights from the BENEFIT StudyHigher baseline serum alpha-linolenic acid levels predict reduced multiple sclerosis activity, relapses, and disability progression up to 11 years post clinical onset in a large prospective study.Oct 4, 2025
Loading comments...
MedXY briefing

Get the free newsletter

Evidence-led clinical news, trends, and analysis—delivered to your inbox.

Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story